| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10745534 | Parkinsonism & Related Disorders | 2014 | 6 Pages |
Abstract
STN-DBS is an efficient treatment of advanced PD for all treated age-groups. Provided strict inclusion criteria are respected, older age and longer disease duration are associated with slightly worse effects mainly on L-dopa-resistant symptoms.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Ali Shalash, Athanasia Alexoudi, Karina Knudsen, Jens Volkmann, Maximilian Mehdorn, Günther Deuschl,